{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:06:36Z","timestamp":1793325996654,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003033","name":"Argentina Ministry of Science Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017700","name":"Sales Foundation Garden Arboretum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA221208"],"award-info":[{"award-number":["CA221208"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017651","name":"Richard Lounsbery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["2020-01552"],"award-info":[{"award-number":["2020-01552"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022965","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["NIH-CA221208"],"award-info":[{"award-number":["NIH-CA221208"]}],"id":[{"id":"10.13039\/100022965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008777","name":"Bunge y Born Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008777","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011619","name":"Society for Immunotherapy of Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"National Agency for the Promotion of Research Technological Development and Innovation","doi-asserted-by":"publisher","award":["PICT 2016-0205"],"award-info":[{"award-number":["PICT 2016-0205"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"National Agency for the Promotion of Research Technological Development and Innovation","doi-asserted-by":"publisher","award":["PICT 2017-0494"],"award-info":[{"award-number":["PICT 2017-0494"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.immuni.2025.04.027","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T10:36:22Z","timestamp":1747391782000},"page":"1553-1571.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells"],"prefix":"10.1016","volume":"58","author":[{"given":"Ada G.","family":"Blidner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila A.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn P.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Cagnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Bannoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montana N.","family":"Manselle Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"P\u00e9rez S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s A.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s I.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Sarrias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Dalotto-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina G.","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Laura","family":"Giribaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Stupirski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Cerliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Bellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Salatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda F.","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina V.","family":"Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn C.","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego O.","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-8735","authenticated-orcid":false,"given":"Gabriel A.","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2025.04.027_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41577-024-01062-0","article-title":"Defining myeloid-derived suppressor cells","volume":"24","author":"Akkari","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","article-title":"Therapeutic targeting of tumour myeloid cells","volume":"23","author":"Barry","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2025.04.027_bib3","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.04.027_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.immuni.2024.12.009","article-title":"Adaptations of neutrophils in cancer","volume":"58","author":"Ng","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ccell.2023.02.009","article-title":"Functional states of myeloid cells in cancer","volume":"41","author":"van Vlerken-Ysla","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib6","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.4049\/jimmunol.1401144","article-title":"Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments","volume":"194","author":"Blidner","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ccr.2011.02.005","article-title":"Targeting the ANG2\/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells","volume":"19","author":"Mazzieri","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2013.08.025","article-title":"Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2","volume":"39","author":"Cui","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2025.04.027_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41577-022-00737-w","article-title":"Myeloid cell-targeted therapies for solid tumours","volume":"23","author":"Goswami","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20554","article-title":"Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells","volume":"539","author":"De Henau","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.04.027_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.immuni.2025.04.027_bib13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 Immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ebiom.2016.02.024","article-title":"Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors","volume":"6","author":"Holmgaard","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.immuni.2025.04.027_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","article-title":"Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells","volume":"25","author":"Shojaei","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2025.04.027_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01566-5","article-title":"Host STING-dependent MDSC mobilization drives extrinsic radiation resistance","volume":"8","author":"Liang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.04.027_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/onc.2016.229","article-title":"Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.immuni.2025.04.027_bib18","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1172\/JCI98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2025.04.027_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.it.2015.02.005","article-title":"Myeloid cell-driven angiogenesis and immune regulation in tumors","volume":"36","author":"Rivera","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri3064","article-title":"The parallel lives of angiogenesis and immunosuppression: cancer and other tales","volume":"11","author":"Motz","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: Markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.immuni.2020.03.004","article-title":"The unfolded protein response mediator PERK governs myeloid cell-driven immunosuppression in tumors through inhibition of STING signaling","volume":"52","author":"Mohamed","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2014.08.015","article-title":"The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors","volume":"41","author":"Thevenot","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","article-title":"Fatty acid transport protein 2 reprograms neutrophils in cancer","volume":"569","author":"Veglia","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.04.027_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","article-title":"An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis","volume":"625","author":"LaMarche","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.04.027_bib26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s43018-023-00620-0","article-title":"Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade","volume":"4","author":"Goswami","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.immuni.2025.04.027_bib27","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1172\/JCI45862","article-title":"Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice","volume":"121","author":"Lu","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2025.04.027_bib28","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","article-title":"Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells","volume":"68","author":"Serafini","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.04.027_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2012.01.011","article-title":"Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression","volume":"22","author":"Ostrand-Rosenberg","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.immuni.2025.04.027_bib30","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.04.027_bib31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.04.027_bib32","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI35213","article-title":"Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice","volume":"118","author":"Kujawski","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2025.04.027_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2016.01.014","article-title":"CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation","volume":"44","author":"Kumar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2025.04.027_bib35","series-title":"Essentials of Glycobiology","first-page":"631","article-title":"Glycosylation changes in cancer","author":"Bellis","year":"2022"},{"key":"10.1016\/j.immuni.2025.04.027_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.03.004","article-title":"Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer","volume":"36","author":"Rabinovich","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105400","article-title":"The universe of galectin-binding partners and their functions in health and disease","volume":"299","author":"Troncoso","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.immuni.2025.04.027_bib38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.1772","article-title":"Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10","volume":"10","author":"Ilarregui","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","article-title":"Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration","volume":"37","author":"Starossom","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1163461","article-title":"Natural killer cells require monocytic Gr-1(+)\/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells","volume":"5","author":"Baker","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.immuni.2025.04.027_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/glycob\/cwg010","article-title":"Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages","volume":"13","author":"Correa","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.immuni.2025.04.027_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106984","article-title":"Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1","volume":"26","author":"Rudjord-Levann","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.immuni.2025.04.027_bib44","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1038\/sj.onc.1211029","article-title":"Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells","volume":"27","author":"Hsieh","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.immuni.2025.04.027_bib45","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1158\/0008-5472.CAN-09-4150","article-title":"Tumor cells secrete galectin-1 to enhance endothelial cell activity","volume":"70","author":"Thijssen","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.04.027_bib46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","article-title":"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors","volume":"156","author":"Croci","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1873-3468.14047","article-title":"Galectin-1-RNA interaction map reveals potential regulatory roles in angiogenesis","volume":"595","author":"Wei","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.immuni.2025.04.027_bib48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/2326-6066.CIR-20-0663","article-title":"Myeloma-secreted Galectin-1 potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells","volume":"9","author":"Lim","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2025.04.027_bib49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1535-6108(04)00024-8","article-title":"Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege","volume":"5","author":"Rubinstein","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2014.11.009","article-title":"Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation","volume":"27","author":"Rutkowski","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102950118","article-title":"Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8(+) regulatory T cells","volume":"118","author":"Cagnoni","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.04.027_bib52","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1084\/jem.20111665","article-title":"Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma","volume":"209","author":"Croci","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2025.04.027_bib53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/0008-5472.CAN-12-2418","article-title":"Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease","volume":"73","author":"Dalotto-Moreno","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.04.027_bib54","doi-asserted-by":"crossref","first-page":"E3769","DOI":"10.1073\/pnas.1722434115","article-title":"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk","volume":"115","author":"Orozco","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.04.027_bib55","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/0008-5472.CAN-23-0046","article-title":"Galectin-1 mediates chronic STING activation in tumors to promote metastasis through MDSC recruitment","volume":"83","author":"Nambiar","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.04.027_bib56","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1158\/1078-0432.CCR-18-3870","article-title":"Impact of galectins in resistance to anticancer therapies","volume":"26","author":"Navarro","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2025.04.027_bib57","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1172\/JCI129025","article-title":"Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance","volume":"129","author":"Nambiar","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2025.04.027_bib58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214350120","article-title":"Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology","volume":"120","author":"Bannoud","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2025.04.027_bib59","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Mari\u00f1o","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2025.04.027_bib60","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201803","article-title":"Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice","volume":"218","author":"Veglia","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2025.04.027_bib61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-0716-1060-2_10","article-title":"In vitro generation of murine myeloid-derived suppressor cells, analysis of markers, developmental commitment, and function","volume":"2236","author":"Eckert","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2025.04.027_bib63","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib64","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1074\/jbc.M110.171256","article-title":"Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation","volume":"286","author":"Jerke","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.immuni.2025.04.027_bib65","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib66","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib67","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.177.4.2431","article-title":"Activation of murine CD4+ and CD8+ T lymphocytes leads to dramatic remodeling of N-linked glycans","volume":"177","author":"Comelli","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05770-9","article-title":"Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans","volume":"9","author":"Giovannone","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.04.027_bib69","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.4049\/jimmunol.179.12.8216","article-title":"Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins","volume":"179","author":"Bax","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.chembiol.2020.12.005","article-title":"Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteins","volume":"28","author":"Park","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.immuni.2025.04.027_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100882","article-title":"Structural and functional diversity of neutrophil glycosylation in innate immunity and related disorders","volume":"79","author":"Ugonotti","year":"2021","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.immuni.2025.04.027_bib72","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.aaz2121","article-title":"The N-glycome regulates the endothelial-to-hematopoietic transition","volume":"370","author":"Kasper","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2025.04.027_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2025.04.027_bib74","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1096\/fj.201902542R","article-title":"Regulation of neutrophil function by selective targeting of glycan epitopes expressed on the integrin CD11b\/CD18","volume":"34","author":"Kelm","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.immuni.2025.04.027_bib75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.trecan.2018.05.009","article-title":"Glycosylation and integrin regulation in cancer","volume":"4","author":"Marsico","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.immuni.2025.04.027_bib76","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4049\/jimmunol.177.2.796","article-title":"Clustering of pre-B cell integrins induces galectin-1-dependent pre-B cell receptor relocalization and activation","volume":"177","author":"Rossi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib77","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1096\/fj.11-197541","article-title":"Binding of galectin-1 to \u03b1IIb\u03b2\u2083 integrin triggers \u201coutside-in\u201d signals, stimulates platelet activation, and controls primary hemostasis","volume":"26","author":"Romaniuk","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.immuni.2025.04.027_bib78","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/2326-6066.CIR-23-0496","article-title":"LILRB3 supports immunosuppressive activity of myeloid cells and tumor development","volume":"12","author":"Huang","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2025.04.027_bib79","article-title":"Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.immuni.2025.04.027_bib80","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation","volume":"409","author":"Demetriou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.04.027_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21550-4","article-title":"Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.04.027_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2025.04.027_bib83","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.immuni.2017.07.020","article-title":"The DNA methylcytosine dioxygenase Tet2 sustains immunosuppressive function of tumor-infiltrating myeloid cells to promote melanoma progression","volume":"47","author":"Pan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.04.027_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj7552","article-title":"A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis","volume":"16","author":"Li","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2025.04.027_bib85","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.04.027_bib86","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41590-024-01936-4","article-title":"ZBTB46 coordinates angiogenesis and immunity to control tumor outcome","volume":"25","author":"Kabir","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib87","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4049\/jimmunol.178.1.436","article-title":"A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte\/macrophage physiology through a nonapoptotic ERK-dependent pathway","volume":"178","author":"Barrionuevo","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2025.04.027_bib89","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/glycob\/cwad065","article-title":"A single-step, rapid, and versatile method for simultaneous detection of cell surface glycan profiles using fluorochrome-conjugated lectins","volume":"33","author":"Torres","year":"2023","journal-title":"Glycobiology"},{"key":"10.1016\/j.immuni.2025.04.027_bib88","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jcp.20143","article-title":"Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions","volume":"202","author":"Lamb","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.immuni.2025.04.027_bib90","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1021\/pr401092y","article-title":"Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC","volume":"13","author":"Saldova","year":"2014","journal-title":"J. Proteome Res."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325001906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325001906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:26:08Z","timestamp":1762363568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761325001906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1074761325001906"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2025.04.027","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2025.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}